首页> 外文期刊>Cytopathology >Immunocytochemistry in Europe: results of the European Federation of Cytology Societies (EFCS) inquiry.
【24h】

Immunocytochemistry in Europe: results of the European Federation of Cytology Societies (EFCS) inquiry.

机译:欧洲的免疫细胞化学:欧洲细胞学学会联合会(EFCS)查询的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: This report describes the results of the first chosen topic of the European Federation of Cytology Societies (EFCS) scientific committee, which concerns the application of immunocytochemistry (ICC) to cytological material. While ICC has become an important ancillary method, not only for diagnosis but also to assess prognostic and predictive factors on cytological material, there are many different methodologies used and the lack of standardization has been criticized. This inquiry aimed first to obtain an overview of the techniques used and second to suggest mechanisms for standardization and quality control. METHODS: We report the results of 28 replies from 13 countries to a web-based inquiry into types of specimens, preparations and technical methods. RESULTS: Conventional smears were the preparations most commonly used, followed by cytospins, cell blocks and liquid-based preparations, in that order. Avidin-biotin complex, labelled streptavidin-biotin or peroxidase anti-peroxidase were used in 61% and enhanced-polymer technology in 39%. Automated staining techniques were used by 64%. More than half used the same antibody dilutions as histopathology although only 20% used cell blocks. CONCLUSION: Reduction of variability by using automation, appropriate controls and customized dilution of antibodies according to different samples could improve the quality of ICC and standardize the techniques, along with quality control and quality assurance measures.
机译:目的:本报告描述了欧洲细胞学协会(EFCS)科学委员会第一个选定主题的结果,该主题涉及免疫细胞化学(ICC)在细胞学材料中的应用。尽管ICC已成为重要的辅助方法,不仅用于诊断,而且还用于评估细胞学材料的预后和预测因素,但仍使用了许多不同的方法,并且批评缺乏标准化。这项调查的目的是首先获得所使用技术的概述,其次提出标准化和质量控制的机制。方法:我们报告了来自13个国家的28个答复的结果,这些答复是对标本类型,制备方法和技术方法进行基于网络的查询的。结果:常规涂片是最常用的制剂,其次是细胞纺锤体,细胞块和液体制剂。使用抗生物素蛋白-生物素复合物,标记的链霉亲和素-生物素或过氧化物酶抗过氧化物酶的比例为61%,使用增强聚合物技术的比例为39%。 64%的人使用了自动染色技术。尽管只有20%的细胞块使用了与组织病理学相同的抗体稀释液,但超过一半的样本使用了相同的抗体稀释液。结论:通过使用自动化,适当的对照以及根据不同样品定制的抗体稀释来减少变异性,可以提高ICC的质量并标准化技术,以及质量控制和质量保证措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号